Altre lingue Voyageur Pharmaceuticals Ltd. Toronto S.E.

Azioni

VM

CA92916K1057

Tempo differito Toronto S.E. Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^CAD	-.--%		+7,14%	-.--%

26/04	Voyageur Pharmaceuticals Ltd. Riporta i risultati degli utili per il primo trimestre conclusosi il 29 febbraio 2024	CI
26/03	Voyageur Pharmaceuticals Ltd. Riporta i risultati degli utili per l'intero anno conclusosi il 30 novembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	26/04
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors	03/04
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options	26/03
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	26/03
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	13/03
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development	13/03
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	04/03
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement	04/03
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement	01/03
Voyageur Pharmaceuticals Ltd. announced that it has received CAD 0.4885 million in funding	01/03
Voyageur Pharmaceuticals Ltd. announced that it expects to receive CAD 0.8 million in funding	16/01
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors	21/12
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule	21/12
Voyageur Pharmaceuticals takes major step forward announcing international expansion	18/12
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance	14/12
Voyageur Pharmaceuticals Initiates International Expansion	14/12
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	30/10/23
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium	28/09/23
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media	14/09/23
Voyageur Pharmaceuticals Ltd. Announces Board Changes	01/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Voyageur Pharmaceuticals Ltd. Toronto S.E.

Azioni

VM

CA92916K1057

Altre lingue

Filtri